» Articles » PMID: 18220271

The Lysosomal-mitochondrial Axis in Free Fatty Acid-induced Hepatic Lipotoxicity

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2008 Jan 29
PMID 18220271
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Impaired mitochondrial function is largely thought to be a core abnormality responsible for disease progression in nonalcoholic fatty liver disease (NAFLD). However, the molecular mechanisms resulting in mitochondrial dysfunction in NAFLD remain poorly understood. This study examined the effects of excessive accumulation of free fatty acids (FFAs) in liver cells on mitochondrial function and the role of the lysosomal-mitochondrial axis on lipotoxicity. Primary mouse hepatocytes, HepG2 and McNtcp.24 cells, were treated with varied concentrations of FFAs with different degrees of saturation for up to 24 hours. Mitochondrial function was monitored by real-time imaging, cytochrome c redistribution, and reactive oxygen species (ROS) production. The temporal relationship of lysosomal and mitochondrial permeabilization was established. Activity of the lysosomal protease cathepsin B was suppressed by genetic and pharmacological approaches. Cathepsin B-knockout mice and wild-type animals were place on a high-carbohydrate diet for 16 weeks, and mitochondrial function and liver damage were assessed. Exposure of liver cells to saturated FFAs resulted in mitochondrial depolarization, cytochrome c release, and increased ROS production. Lysosomal permeabilization and cathepsin B redistribution into the cytoplasm occurred several hours prior to mitochondrial dysfunction. Either pharmacological or genetic inhibition of cathepsin B preserved mitochondrial function. Finally, cathepsin B inactivation protected mitochondria, decreased oxidative stress, and attenuated hepatic injury in vivo.

Conclusion: These data strongly suggest excessive accumulation of saturated FFAs in liver cells directly induce mitochondrial dysfunction and oxidative stress. Our data further suggest this process is dependent on lysosomal disruption and activation of cathepsin B.

Citing Articles

GLP1 alleviates oleic acid-propelled lipocalin-2 generation by tumor-infiltrating CD8 T cells to reduce polymorphonuclear MDSC recruitment and enhances viral immunotherapy in pancreatic cancer.

Wu J, Qian P, Han Y, Xu C, Xia M, Zhan P Cell Mol Immunol. 2025; 22(3):282-299.

PMID: 39910336 PMC: 11868399. DOI: 10.1038/s41423-025-01260-3.


Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma.

Alpizar Salazar M, Olguin Reyes S, Medina Estevez A, Saturno Lobos J, De Aldecoa Castillo J, Carrera Aguas J Medicina (Kaunas). 2025; 61(1).

PMID: 39859069 PMC: 11766802. DOI: 10.3390/medicina61010088.


Inhibited peroxidase activity of peroxiredoxin 1 by palmitic acid exacerbates nonalcoholic steatohepatitis in male mice.

Yin W, Xu H, Bai Z, Wu Y, Zhang Y, Liu R Nat Commun. 2025; 16(1):598.

PMID: 39799115 PMC: 11724923. DOI: 10.1038/s41467-025-55939-2.


Molecular Insights into the Inhibition of Lipid Accumulation in Hepatocytes by Unique Extracts of Ashwagandha.

Li D, Han H, Sun Y, Zhang H, Yoshitomi R, Kaul S Int J Mol Sci. 2024; 25(22).

PMID: 39596320 PMC: 11594306. DOI: 10.3390/ijms252212256.


PPARs: modulating lipotoxicity and thus inhibiting fibrosis.

Li W, Zhang C, Wang J Hormones (Athens). 2024; .

PMID: 39500811 DOI: 10.1007/s42000-024-00612-4.


References
1.
Angulo P . Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346(16):1221-31. DOI: 10.1056/NEJMra011775. View

2.
Day C, James O . Steatohepatitis: a tale of two "hits"?. Gastroenterology. 1998; 114(4):842-5. DOI: 10.1016/s0016-5085(98)70599-2. View

3.
Clark J, Brancati F, Diehl A . Nonalcoholic fatty liver disease. Gastroenterology. 2002; 122(6):1649-57. DOI: 10.1053/gast.2002.33573. View

4.
Unger R . Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab. 2003; 14(9):398-403. DOI: 10.1016/j.tem.2003.09.008. View

5.
Feldstein A, Werneburg N, Canbay A, Guicciardi M, Bronk S, Rydzewski R . Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology. 2004; 40(1):185-94. DOI: 10.1002/hep.20283. View